Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1982 Sep;196(3):330–337. doi: 10.1097/00000658-198209000-00012

The use of cyclosporin A in clinical organ grafting.

R Y Calne, D J White
PMCID: PMC1352610  PMID: 7051997

Abstract

Experiments in animals with organ allografts showed that Cyclosporin A (CyA) was an extremely powerful immunosuppressant with a good therapeutic index. A pilot study of the drug in human recipients of renal allografts revealed an unexpected side effect, nephrotoxicity, which made care of patients difficult. Following a policy of deliberate hydration of patients in the perioperative phase and withholding CyA until diuresis was occurring in the graft, excellent results have been obtained in clinical practice. An 82% actuarial functional survival at both one and two years has been obtained in the 59 patients treated with this protocol. A multicenter trial is now in progress in eight centers in Europe, comparing CyA used in the manner described above with conventional azathioprine and steroids. CyA has also been used in 17 recipients of liver allografts, ten of whom are still alive and 11 recipients of segmental pancreatic allografts, one of whom remains off insulin after two and a quarter years. Sudden graft failure occurred between three months and two years in three patients whose pancreatic duct had been occluded. The authors' most recent segmental pancreas graft has been drained into a long roux loop without complications. The main objective in the use of this drug is to obtain consistent immunosuppression without nephrotoxicity. It is possible that maintaining blood level between defined limits would improve results.

Full text

PDF
330

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson J. L., Fowles R. E., Bieber C. P., Stinson E. B. Idiopathic cardiomyopathy, age, and suppressor-cell dysfunction as risk determinants of lymphoma after cardiac transplantation. Lancet. 1978 Dec 2;2(8101):1174–1177. doi: 10.1016/s0140-6736(78)92156-6. [DOI] [PubMed] [Google Scholar]
  2. Calne R. Y., McMaster P., Rolles K., Duffy T. J. Technical observations in segmental pancreas allografting: observations on pancreatic blood flow. Transplant Proc. 1980 Dec;12(4 Suppl 2):51–57. [PubMed] [Google Scholar]
  3. Calne R. Y., Rolles K., White D. J., Thiru S., Evans D. B., McMaster P., Dunn D. C., Craddock G. N., Henderson R. G., Aziz S. Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet. 1979 Nov 17;2(8151):1033–1036. doi: 10.1016/s0140-6736(79)92440-1. [DOI] [PubMed] [Google Scholar]
  4. Calne R. Y., White D. J., Evans D. B., Thiru S., Henderson R. G., Hamilton D. V., Rolles K., McMaster P., Duffy T. J., MacDougall B. R. Cyclosporin A in cadaveric organ transplantation. Br Med J (Clin Res Ed) 1981 Mar 21;282(6268):934–936. doi: 10.1136/bmj.282.6268.934. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Calne R. Y., White D. J., Rolles K., Smith D. P., Herbertson B. M. Prolonged survival of pig orthotopic heart grafts treated with cyclosporin A. Lancet. 1978 Jun 3;1(8075):1183–1185. doi: 10.1016/s0140-6736(78)90971-6. [DOI] [PubMed] [Google Scholar]
  6. Calne R. Y., White D. J., Thiru S., Evans D. B., McMaster P., Dunn D. C., Craddock G. N., Pentlow B. D., Rolles K. Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet. 1978 Dec 23;2(8104-5):1323–1327. doi: 10.1016/s0140-6736(78)91970-0. [DOI] [PubMed] [Google Scholar]
  7. Calne R. Y., Williams R., Lindop M., Farman J. V., Tolley M. E., Rolles K., MacDougall B., Neuberger J., Wyke R. J., Raftery A. T. Improved survival after orthotopic liver grafting. Br Med J (Clin Res Ed) 1981 Jul 11;283(6284):115–118. doi: 10.1136/bmj.283.6284.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dubernard J. M., Traeger J., Neyra P., Touraine J. L., Tranchant D., Blanc-Brunat N. A new method of preparation of segmental pancreatic grafts for transplantation: trials in dogs and in man. Surgery. 1978 Nov;84(5):633–639. [PubMed] [Google Scholar]
  9. Gliedman M. L., Gold M., Whittaker J., Rifkin H., Soberman R., Freed S., Tellis V., Veith F. J. Clinical segmental pancreatic transplantation with ureter-pancreatic duct anastomosis for exocrine drainage. Surgery. 1973 Aug;74(2):171–180. [PubMed] [Google Scholar]
  10. Groth C. G., Lundgren G., Arner P., Collste H., Hårdstedt C., Lewander R., Ostman J. Rejection of isolated pancreatic allografts in patients with with diabetes. Surg Gynecol Obstet. 1976 Dec;143(6):933–940. [PubMed] [Google Scholar]
  11. Hows J. M., Gordon-Smith E. C. Nephrotoxicity of cyclosporin A. Lancet. 1981 Oct 17;2(8251):876–877. doi: 10.1016/s0140-6736(81)91142-9. [DOI] [PubMed] [Google Scholar]
  12. Largiadèr F., Kolb E., Binswanger U. A long-term functioning human pancreatic islet allotransplant. Transplantation. 1980;29(1):76–77. doi: 10.1097/00007890-198001000-00017. [DOI] [PubMed] [Google Scholar]
  13. Najarian J. S., Sutherland D. E., Simmons R. L., Howard R. J., Kjellstrand C. M., Ramsay R. C., Goetz F. C., Fryd D. S., Sommer B. G. Ten year experience with renal transplantation in juvenile onset diabetics. Ann Surg. 1979 Oct;190(4):487–500. doi: 10.1097/00000658-197910000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Sutherland D. E., Goetz F. C., Rynasiewicz J. J., Baumgartner D., White D. C., Elick B. A., Najarian J. S. Segmental pancreas transplantation from living related and cadaver donors: a clinical experience. Surgery. 1981 Aug;90(2):159–169. [PubMed] [Google Scholar]
  15. White D. J., Plumb A., Calne R. Y. The immune status of transplant recipients immunosuppressed with cyclosporin-A. Transplant Proc. 1981 Sep;13(3):1666–1668. [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES